- E-postRolf.Bjerkvig@uib.no
- Telefon+47 55 58 63 52+47 951 18 268
- BesøksadresseJonas Lies vei 91
- PostadressePostboks 78045020 Bergen
Rolf Bjerkvig (f. 1953) er professor for cellebiologi og har siden 80tallet jobbet i eksperimentell kreftbiologi.
I 2015 ble Bjerkvig tildelt kong Olav V kreftforskningsprisen.
- 2020. Tumor-penetrating peptide for systemic targeting of Tenascin-C. Scientific Reports.
- 2020. Suicide gene therapy for the treatment of high-grade glioma: past lessons, present trends, and future prospects. Neuro-Oncology Advances (NOA).
- 2020. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology. Acta Neuropathologica. 1-31.
- 2020. Identification of a Blood-Based Protein Biomarker Panel for Lung Cancer Detection. Cancers.
- 2020. AN1-type zinc finger protein 3 (ZFAND3) is a transcriptional regulator that drives Glioblastoma invasion. Nature Communications.
- 2019. Therapeutic implications of altered cholesterol homeostasis mediated by loss of CYP46A1 in human glioblastoma. EMBO Molecular Medicine.
- 2019. Peptide-guided nanoparticles for glioblastoma targeting. Journal of Controlled Release. 109-118.
- 2019. Long Noncoding RNA SChLAP1 Forms a Growth-Promoting Complex with HNRNPL in Human Glioblastoma through Stabilization of ACTN4 and Activation of NF-kappa B Signaling. Clinical Cancer Research. 6868-6881.
- 2019. Improved drug delivery to brain metastases by peptide-mediated permeabilization of the blood-brain barrier. Molecular Cancer Therapeutics. 2171-2181.
- 2019. Effective treatment of metastatic melanoma by combining mapk and pi3k signaling pathway inhibitors. International Journal of Molecular Sciences. 1-19.
1987: Dr. philos. The Gade Institute of Pathology, University of Bergen
1981: M.Sc. Immunology, University of San Francisco, 1981.
Kompetansefelt